IDEXX Laboratories, Inc. (IDXX) Income Statement
IDXX 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsIDXX revenue and net income
Where IDXX's revenue goes
2025Each bar shows an amount and its share of revenue. IDXX kept 24.6% of revenue as net income.
IDXX profit margins
IDXX growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +10.4% | +8.5% | +9.7% | +10.4% |
| Gross profit | +11.8% | +9.9% | +11.1% | +11.6% |
| Operating income | +20.5% | +14.8% | +14.4% | +16.3% |
| Net income | +19.3% | +16.0% | +12.7% | +18.6% |
| EPS (diluted) | +16.2% | +17.6% | +15.1% | +20.0% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
IDXX quarterly EPS vs estimates
IDEXX beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: November 2, 2026 (estimate $3.70).
IDXX income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.30B | $3.90B | $3.66B | $3.37B | $3.22B | $2.71B | $2.41B | $2.21B | $1.97B | $1.78B |
| Cost of revenue | $1.64B | $1.52B | $1.47B | $1.36B | $1.33B | $1.14B | $1.04B | $971.7M | $871.7M | $800.0M |
| Gross profit | $2.66B | $2.38B | $2.19B | $2.00B | $1.89B | $1.57B | $1.37B | $1.24B | $1.10B | $975.4M |
| Research & development | $251.2M | $219.8M | $191.0M | $254.8M | $161.0M | $141.2M | $133.2M | $117.9M | $109.2M | $101.1M |
| Sales, general & admin | $1.05B | $1.03B | $901.9M | $850.8M | $796.4M | $735.3M | $679.5M | $632.3M | $575.2M | $524.1M |
| Total operating expenses | $1.30B | $1.25B | $1.09B | $1.11B | $957.4M | $876.5M | $812.7M | $750.2M | $684.4M | $625.2M |
| Operating income | $1.36B | $1.13B | $1.10B | $898.8M | $932.0M | $694.5M | $552.8M | $491.3M | $413.0M | $350.2M |
| Interest income | $3.0M | $12.7M | $2.2M | $1.1M | $434,000 | $586,000 | $427,000 | $1.2M | $5.3M | $3.7M |
| Interest expense | $38.3M | $31.2M | $36.0M | $38.8M | $29.4M | $32.5M | $30.6M | $33.6M | $32.0M | $28.4M |
| Income before taxes | $1.32B | $1.11B | $1.06B | $860.0M | $902.7M | $662.0M | $522.2M | $457.7M | $381.1M | $321.8M |
| Income taxes | $264.7M | $222.0M | $216.1M | $180.9M | $157.8M | $79.9M | $94.4M | $80.7M | $117.8M | $99.8M |
| Net income | $1.06B | $887.9M | $845.0M | $679.1M | $744.8M | $581.8M | $427.7M | $377.0M | $263.1M | $222.0M |
| EBITDA | $1.51B | $1.28B | $1.10B | $1.01B | $1.04B | $790.5M | $640.9M | $574.5M | $496.2M | $428.5M |
| EPS (diluted) | $13.07 | $11.25 | $10.07 | $8.03 | $8.61 | $6.46 | $4.88 | $4.27 | $3.28 | $2.45 |
| Gross margin | 61.8% | 61.0% | 59.8% | 59.5% | 58.8% | 58.0% | 56.7% | 56.1% | 55.7% | 54.9% |
| Operating margin | 31.6% | 29.0% | 30.0% | 26.7% | 29.0% | 25.7% | 23.0% | 22.2% | 21.0% | 19.7% |
| Net margin | 24.6% | 22.8% | 23.1% | 20.2% | 23.2% | 21.5% | 17.8% | 17.0% | 13.4% | 12.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.22B | $1.14B | $1.09B | $1.11B | $1.11B | $998.4M | $954.3M | $975.5M | $1.00B | $964.1M | $901.6M | $915.5M |
| Cost of revenue | $437.5M | $418.1M | $432.5M | $421.9M | $414.7M | $375.0M | $383.6M | $379.5M | $382.7M | $371.0M | $375.4M | $367.5M |
| Gross profit | $779.1M | $722.7M | $658.1M | $683.4M | $694.7M | $623.4M | $570.7M | $596.0M | $620.9M | $593.1M | $526.2M | $548.0M |
| Research & development | $65.4M | $65.8M | $66.8M | $63.4M | $61.9M | $59.1M | $57.7M | $54.0M | $55.5M | $52.6M | $51.8M | $48.0M |
| Sales, general & admin | $288.1M | $294.4M | $275.7M | $265.1M | $259.8M | $247.8M | $251.2M | $238.2M | $299.9M | $241.5M | $229.1M | $224.7M |
| Total operating expenses | $353.5M | $360.2M | $342.5M | $328.5M | $321.7M | $306.8M | $309.0M | $292.1M | $355.4M | $294.1M | $280.9M | $272.7M |
| Operating income | $425.6M | $362.6M | $315.6M | $354.8M | $373.0M | $316.5M | $261.7M | $303.9M | $263.8M | $299.0M | $245.3M | $275.3M |
| Interest income | $606,000 | $597,000 | $587,000 | $580,000 | $627,000 | $1.2M | $2.2M | $2.7M | $3.4M | $4.4M | $3.6M | $1.3M |
| Interest expense | $10.2M | $7.7M | $10.5M | $10.7M | $11.3M | $7.7M | $7.5M | $7.7M | $8.1M | $7.9M | $9.3M | $8.6M |
| Income before taxes | $417.2M | $355.4M | $307.0M | $344.8M | $362.4M | $310.1M | $256.4M | $298.9M | $259.1M | $295.5M | $239.7M | $267.9M |
| Income taxes | $78.8M | $77.0M | $58.8M | $70.2M | $68.4M | $67.4M | $40.2M | $66.1M | $55.8M | $59.9M | $45.1M | $55.7M |
| Net income | $338.4M | $278.4M | $248.2M | $274.6M | $294.0M | $242.7M | $216.1M | $232.8M | $203.3M | $235.6M | $194.5M | $212.2M |
| EBITDA | $468.5M | $400.9M | $356.2M | $392.1M | $409.4M | $351.8M | $298.6M | $342.0M | $300.7M | $334.6M | $278.7M | $305.8M |
| EPS (diluted) | $4.27 | $3.47 | $3.08 | $3.40 | $3.63 | $2.96 | $2.62 | $2.80 | $3.02 | $2.81 | $2.32 | $2.53 |
| Gross margin | 64.0% | 63.4% | 60.3% | 61.8% | 62.6% | 62.4% | 59.8% | 61.1% | 61.9% | 61.5% | 58.4% | 59.9% |
| Operating margin | 35.0% | 31.8% | 28.9% | 32.1% | 33.6% | 31.7% | 27.4% | 31.2% | 26.3% | 31.0% | 27.2% | 30.1% |
| Net margin | 27.8% | 24.4% | 22.8% | 24.8% | 26.5% | 24.3% | 22.7% | 23.9% | 20.3% | 24.4% | 21.6% | 23.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in IDXX's financial statements (latest annual report filed February 20, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
IDXX financial results
In fiscal year 2025 (ended December 31, 2025), IDEXX reported revenue of $4.3 billion, up 10.4% from the year before. It had net income of $1.1 billion (up 19.3%), a net profit margin of 24.6%. Diluted earnings per share came to $13.07. Over five years revenue grew at an average rate of 9.7% a year.
See the IDXX stock overview for the latest quote and news, or the IDXX chart for price history and technical indicators.
IDXX income statement FAQ
What is IDEXX's annual revenue?
IDEXX reported total revenue of $4.3 billion for fiscal year 2025, which ended on December 31, 2025. That was up 10.4% from $3.9 billion the previous year.
Is IDEXX profitable?
Yes. IDEXX reported net income of $1.1 billion in fiscal 2025, a net profit margin of 24.6%; its operating margin was 31.6%.
What is IDEXX's gross margin?
IDEXX's gross margin was 61.8% in fiscal 2025: for every $100 of revenue, IDEXX kept $62 after the direct cost of its products and services.
How much does IDEXX spend on research and development?
IDEXX spent $251.2 million on research and development in fiscal 2025, 5.8% of revenue.
How fast is IDEXX growing?
Revenue grew 9.7% a year on average over the last five fiscal years, from $2.7 billion to $4.3 billion.
What are IDEXX's earnings per share?
IDEXX earned $13.07 per diluted share in fiscal 2025, compared with $11.25 a year earlier.
When will IDEXX report its next earnings?
IDEXX is expected to report results for the quarter ending September 30, 2026 on November 2, 2026 before the market opens.
When does IDEXX's fiscal year end?
IDEXX's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 20, 2026.